Gentian Diagnostics Future Growth
Future criteria checks 5/6
Gentian Diagnostics is forecast to grow earnings and revenue by 119.6% and 20.9% per annum respectively while EPS is expected to grow by 119.8% per annum.
Key information
119.6%
Earnings growth rate
119.8%
EPS growth rate
| Medical Equipment earnings growth | 18.3% |
| Revenue growth rate | 20.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 01 May 2024 |
Recent future growth updates
Recent updates
Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report
Feb 14
Here's Why We're Not At All Concerned With Gentian Diagnostics' (OB:GENT) Cash Burn Situation
Oct 28We're Not Worried About Gentian Diagnostics' (OB:GENT) Cash Burn
May 11Can You Imagine How Gentian Diagnostics' (OB:GENT) Shareholders Feel About The 57% Share Price Increase?
Mar 20What Percentage Of Gentian Diagnostics AS (OB:GENT) Shares Do Insiders Own?
Feb 21Have Insiders Been Selling Gentian Diagnostics AS (OB:GENT) Shares?
Jan 17
Gentian Diagnostics AS (OB:GENT): When Will It Breakeven?
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 263 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 226 | 14 | 9 | 18 | 1 |
| 12/31/2024 | 174 | 8 | -5 | 5 | 1 |
| 3/31/2024 | 149 | -6 | 15 | 21 | N/A |
| 12/31/2023 | 142 | -11 | 11 | 15 | N/A |
| 9/30/2023 | 135 | -5 | -12 | -7 | N/A |
| 6/30/2023 | 126 | -14 | -6 | 0 | N/A |
| 3/31/2023 | 122 | -18 | -19 | -6 | N/A |
| 12/31/2022 | 112 | -24 | -29 | -14 | N/A |
| 9/30/2022 | 106 | -29 | -34 | -19 | N/A |
| 6/30/2022 | 100 | -26 | -43 | -26 | N/A |
| 3/31/2022 | 99 | -26 | -42 | -29 | N/A |
| 12/31/2021 | 100 | -25 | -40 | -27 | N/A |
| 9/30/2021 | 99 | -19 | -24 | -9 | N/A |
| 6/30/2021 | 96 | -19 | -27 | -16 | N/A |
| 3/31/2021 | 84 | -17 | -20 | -12 | N/A |
| 12/31/2020 | 79 | -17 | -19 | -13 | N/A |
| 9/30/2020 | 72 | -21 | -16 | -13 | N/A |
| 6/30/2020 | 70 | -19 | -16 | -13 | N/A |
| 3/31/2020 | 62 | -38 | -28 | -25 | N/A |
| 12/31/2019 | 55 | -40 | -26 | -21 | N/A |
| 9/30/2019 | 44 | -46 | -25 | -20 | N/A |
| 6/30/2019 | 48 | -41 | -22 | -17 | N/A |
| 3/31/2019 | 47 | -23 | -18 | -12 | N/A |
| 12/31/2018 | 46 | -20 | -17 | -11 | N/A |
| 9/30/2018 | 51 | -12 | -23 | -18 | N/A |
| 6/30/2018 | 41 | -16 | -24 | -19 | N/A |
| 3/31/2018 | 40 | -14 | -21 | -16 | N/A |
| 12/31/2017 | 35 | -15 | N/A | -19 | N/A |
| 9/30/2017 | 34 | -13 | N/A | -19 | N/A |
| 6/30/2017 | 32 | -12 | N/A | -18 | N/A |
| 3/31/2017 | 30 | -13 | N/A | -16 | N/A |
| 12/31/2016 | 31 | -9 | N/A | -8 | N/A |
| 12/31/2015 | 26 | -3 | N/A | -5 | N/A |
| 12/31/2014 | 25 | -3 | N/A | -2 | N/A |
| 12/31/2013 | 23 | 1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: GENT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GENT is expected to become profitable in the next 3 years.
Revenue vs Market: GENT's revenue (20.9% per year) is forecast to grow faster than the Norwegian market (1.7% per year).
High Growth Revenue: GENT's revenue (20.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GENT's Return on Equity is forecast to be high in 3 years time